Clinical Trials Directory

Trials / Completed

CompletedNCT04785703

Prolactin Hormone in Oral Lichen Planus

Prolactin Hormone in Oral Lichen Planus Tissue Samples

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
October University for Modern Sciences and Arts · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Oral lichen planus (OLP) is one of the most common mucosal diseases with autoimmune etio-pathogenesis with involvement of various cytokines similar to psoriasis.It generally occurs more commonly in females, in a ratio of 3:2. prolactin (PRL),It is a peptide hormone that has a role in autoimmune related diseases like systemic lupus erythematosus and , rheumatoid Artheritis. The role of PrL in OLP pathogenesis was never investigated.the aim of this study is to investigate the expression of PRL receptors in tissue biopsies of OLP patients.

Conditions

Timeline

Start date
2020-06-19
Primary completion
2020-08-22
Completion
2020-12-10
First posted
2021-03-08
Last updated
2021-03-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04785703. Inclusion in this directory is not an endorsement.

Prolactin Hormone in Oral Lichen Planus (NCT04785703) · Clinical Trials Directory